George Golumbeski, Director at ENANTA PHARMACEUTICALS INC (ENTA), sold 2,272 shares at $90.03 ($205K) on 2019-02-11, disclosed to the SEC on 2019-02-13.
Open-market sale of $205k ENTA by Director. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| Filing → |
| STTK | BUY | 2022-04-26 | $193K | — | Filing → |
| ENTA | SELL | 2019-03-06 | $962K | — | Filing → |
| ENTA | SELL | 2019-02-13 | $2.4M | — | Filing → |